Cambridge Investment Research Advisors, Inc. - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 79 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$265
+37.3%
138,172
+2.9%
0.00%0.0%
Q2 2023$193
-35.5%
134,332
-5.7%
0.00%0.0%
Q1 2023$299
+74.9%
142,403
-6.0%
0.00%0.0%
Q4 2022$171
-99.9%
151,571
+0.6%
0.00%0.0%
Q3 2022$246,000
+26.2%
150,661
+1.3%
0.00%0.0%
Q2 2022$195,000
-16.7%
148,739
+2.4%
0.00%0.0%
Q1 2022$234,000
-26.2%
145,207
-5.1%
0.00%0.0%
Q4 2021$317,000
-50.3%
153,027
-7.0%
0.00%
-66.7%
Q3 2021$638,000
+18.4%
164,498
-2.3%
0.00%0.0%
Q2 2021$539,000
+34.1%
168,316
-6.3%
0.00%
+50.0%
Q4 2020$402,000
-21.2%
179,556
-6.1%
0.00%
-33.3%
Q3 2020$510,000
-17.9%
191,195
-5.8%
0.00%
-40.0%
Q2 2020$621,000
+54.9%
202,927
-0.9%
0.01%
+25.0%
Q1 2020$401,000
-26.4%
204,824
+7.4%
0.00%0.0%
Q4 2019$545,000
-36.4%
190,680
-18.4%
0.00%
-50.0%
Q3 2019$857,000
-11.2%
233,644
+0.5%
0.01%
-11.1%
Q2 2019$965,000
+7.2%
232,554
+32.0%
0.01%0.0%
Q1 2019$900,000176,2220.01%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders